医学
胼胝体
牙病
癫痫
胼胝体发育不全
复合杂合度
突变
疾病
病理
遗传学
基因
精神科
生物
作者
Masahiro Ando,Yujiro Higuchi,Jun‐Hui Yuan,Ashio Yoshimura,Takaki Taniguchi,Jun Takei,Mika Takeuchi,Yoshihiro Hiramatsu,Fumitaka Shimizu,Masaya Kubota,Akari Takeshima,Takahiro Ueda,Kishin Koh,Utako Nagaoka,Takashi Tokashiki,Setsu Sawai,Yusuke Sakiyama,Akihiro Hashiguchi,Ryota Sato,Takashi Kanda,Yuji Okamoto,Hiroshi Takashima
摘要
Recessive mutations in SLC12A6 have been linked to hereditary motor sensory neuropathy with agenesis of the corpus callosum. Patients with early-onset peripheral neuropathy associated with SLC12A6 heterozygous variants were reported in 2016. Only five families and three variants have been reported to date, and the spectrum is unclear. Here, we aim to describe the clinical and mutation spectra of SLC12A6-related Charcot-Marie-Tooth (CMT) disease in Japanese patients.We extracted SLC12A6 variants from our DNA microarray and targeted resequencing data obtained from 2598 patients with clinically suspected CMT who were referred to our genetic laboratory by neurological or neuropediatric departments across Japan. And we summarized the clinical and genetic features of these patients.In seven unrelated families, we identified one previously reported and three novel likely pathogenic SLC12A6 heterozygous variants, as well as two variants of uncertain significance. The mean age of onset for these patients was 17.5 ± 16.1 years. Regarding electrophysiology, the median motor nerve conduction velocity was 39.6 ± 9.5 m/sec. For the first time, we observed intellectual disability in three patients. One patient developed epilepsy, and her brain MRI revealed frontal and temporal lobe atrophy without changes in white matter and corpus callosum.Screening for the SLC12A6 gene should be considered in patients with CMT, particularly those with central nervous system lesions, such as cognitive impairment and epilepsy, regardless of the CMT subtype.
科研通智能强力驱动
Strongly Powered by AbleSci AI